Axonal pathology in traumatic brain injury
2012/01/28 by Victoria E. Johnson, William Stewart, Douglas H. Smith · 42 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Traumatic Brain Injury and Neurovascular Disturbances #Traumatic Brain Injury Research #S100 Proteins and Annexins
paper · doi:10.1016/j.expneurol.2012.01.013
Citations
Cited by
- Design of armor for protection against blast and impact
- Cognitive impairment after traumatic brain injury: The role of MRI and possible pathological basis
- Time-dependent diffusion in undulating structures: Impact on axon\n diameter estimation
- Neuroinflammation and blood–brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets
- Astrocytes in ischemic stroke: Crosstalk in central nervous system and therapeutic potential
- The Dynamics of Concussion: Mapping Pathophysiology, Persistence, and Recovery With Causal-Loop Diagramming
- Optimal Trajectories of Brain State Transitions
- Stability of Traveling Fronts of the FitzHugh-Nagumo Equations on Cylindrical Surfaces
- Bio-inspired electronics: Soft, biohybrid, and “living” neural interfaces
- Creatine supplementation for brain metabolic stress: a narrative review
- Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer Disease
- Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes
- A complex network perspective on brain disease
- Reaction time impairments in decision-making networks as a diagnostic marker for traumatic brain injuries and neurodegenerative diseases
- Evaluating the therapeutic effect of LIPUS in the early stage of traumatic brain injury using FA and T2* in rats
- Uncovering injury-specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injury
- Modelling human pathology of traumatic brain injury in animal models
- Therapy development for diffuse axonal injury. [europepmc]
- Animal models of traumatic brain injury. [europepmc]
- Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. [europepmc]
- Chronic neuropathologies of single and repetitive TBI: substrates of dementia? [europepmc]
- Molecular mechanisms of cognitive dysfunction following traumatic brain injury. [europepmc]
- Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes. [europepmc]
- The new neurometabolic cascade of concussion. [europepmc]
- Merging pathology with biomechanics using CHIMERA (Closed-Head Impact Model of Engineered Rotational Acceleration): a novel, surgery-free model of traumatic brain injury. [europepmc]
- The neuropathology of traumatic brain injury. [europepmc]
- Astrocyte roles in traumatic brain injury. [europepmc]
- Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. [europepmc]
- Blood-Brain Barrier Disruption Is an Early Event That May Persist for Many Years After Traumatic Brain Injury in Humans. [europepmc]
- Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism. [europepmc]
- Traumatic Axonal Injury: Mechanisms and Translational Opportunities. [europepmc]
- Blood biomarkers for brain injury: What are we measuring? [europepmc]
- Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics. [europepmc]
- Optimal trajectories of brain state transitions. [europepmc]
- Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players. [europepmc]
- The chronic and evolving neurological consequences of traumatic brain injury. [europepmc]
- Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets. [europepmc]
- Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia. [europepmc]
- Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI. [europepmc]
- NAD + metabolism: pathophysiologic mechanisms and therapeutic potential. [europepmc]
- The synapse in traumatic brain injury. [europepmc]
- Traumatic Brain Injury and Risk of Neurodegenerative Disorder. [europepmc]